Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody Deficiency”

362 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 362 results

Large-scale testing (Phase 3)Study completedNCT02269163
What this trial is testing

Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%

Who this might be right for
Primary Immunodeficiency
Prometic Biotherapeutics, Inc. 82
Early research (Phase 1)Study completedNCT05245292
What this trial is testing

3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)

Who this might be right for
Human Immunodeficiency Virus
Rockefeller University 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04983030
What this trial is testing

Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults

Who this might be right for
HIVAcquired Immunodeficiency SyndromeImmunologic Deficiency Syndrome, Acquired+2 more
Boris Juelg, MD PhD 36
Large-scale testing (Phase 3)Study completedNCT00168012
What this trial is testing

Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)

Who this might be right for
AgammaglobulinemiaIgG DeficiencyCommon Variable Immunodeficiency
CSL Behring 42
Not applicableStudy completedNCT03401268
What this trial is testing

Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients

Who this might be right for
Hypogammaglobulinemia
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Study completedNCT02850016
What this trial is testing

Romidepsin Plus 3BNC117 Phase 2a Study

Who this might be right for
Human Immunodeficiency Virus (HIV)
Rockefeller University 48
Not applicableStudy completedNCT03716700
What this trial is testing

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 126
Post-approval studies (Phase 4)Study completedNCT04566692
What this trial is testing

Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Participants and Loading/Maintenance Dosing in Treatment-Naïve Participants With Primary Immunodeficiency

Who this might be right for
Primary Immunodeficiency
Grifols Therapeutics LLC 33
Large-scale testing (Phase 3)Active Not RecruitingNCT06548100
What this trial is testing

The Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)

Who this might be right for
Generalized Lipodystrophy
Regeneron Pharmaceuticals 9
Post-approval studies (Phase 4)Study completedNCT02881437
What this trial is testing

IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQvia

Who this might be right for
Primary Immunodeficiency
University Hospital, Lille 22
Not applicableStudy completedNCT01048372
What this trial is testing

Observational Study of Blood Treated With Cytolin

Who this might be right for
HIV Infections
CytoDyn, Inc. 20
Large-scale testing (Phase 3)Study completedNCT03920072
What this trial is testing

Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd 35
Large-scale testing (Phase 3)WithdrawnNCT03492710
What this trial is testing

Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency

Who this might be right for
Primary Immune Deficiency Disorder
Green Cross Corporation
Testing effectiveness (Phase 2)WithdrawnNCT01443117
What this trial is testing

Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women

Who this might be right for
Pneumococcal InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT00025922
What this trial is testing

Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 240
Large-scale testing (Phase 3)Study completedNCT01461018
What this trial is testing

Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)

Who this might be right for
Primary Immune Deficiency
CSL Behring 22
Large-scale testing (Phase 3)UnknownNCT01992328
What this trial is testing

IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency

Who this might be right for
Asthma
Ajou University School of Medicine 30
Early research (Phase 1)Study completedNCT00027365
What this trial is testing

An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 84
Early research (Phase 1)Study completedNCT00007423
What this trial is testing

Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)Study completedNCT00011037
What this trial is testing

ALVAC-HIV vCP1452 Alone and Combined With MN rgp120

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 160
Load More Results